The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have released updated COVID-19 vaccine recommendations. Highlights include:
People 65 years of age and older who have received a single dose of an updated (bivalent) vaccine may receive one additional bivalent dose at least four months after their initial bivalent dose.
Most people who are immunocompromised who have received a bivalent COVID-19 vaccine may receive an additional bivalent dose at least two months after their previous bivalent dose.
CDC recommends that everyone ages 6 years and older receive an updated (bivalent) mRNA COVID-19 vaccine, regardless of whether they previously completed their (monovalent) primary series. Monovalent (original) mRNA COVID-19 vaccines will no longer be recommended for use in the United States.
People ages 6 years and older who have already received an updated (bivalent) mRNA vaccine do not need to take any action unless they are 65 years or older or immunocompromised.
For young children, multiple doses continue to be recommended and will vary by age, vaccine, and which vaccines were previously received.
View the FDA and CDC websites or ask a local vaccine provider for more information.